Table 4. In vivo anti-cancer effect of Neem (Azadirachta indica) on PCa.
Type of study | Cell line | Type of extract | Concentration | Dosage | Effect | Mechanism | References |
---|---|---|---|---|---|---|---|
In vivo | TRAMP | Nimbolide | 3 mg/kg | 5 times/week for 6–12 weeks | Reduced tumor growth and metastasis | Inhibition of STAT3 phosphorylation, decrease in Ki-67 | (8) |
In vivo | C4-2B and PC-3M-luc2 in nude mice | Ethanolic Neem leaf extract | 100, 200 mg/kg | 6 times/week for 8–11 weeks | Inhibited tumor growth | Promotion of hyalinization and apoptosis | (12) |
In vivo | LNCaP-luc2 xenograft in nude mice | SENL | 100, 200 mg/kg | 6 times/week for 9 weeks | Reduced tumor growth | Promotion of hyalinization and apoptosis | (13) |
PCa, prostate cancer; SENL, supercritical extract of Neem leaves.